-
-
-
[1] Siegel R L, Miller K D, Jemal A.Cancer Statistics, 2017[J].CA Cancer J Clin, 2017, 67 (1): 7-30.
[2] Chen W, Zheng R, Baade P D, et al.Cancer statistics in China, 2015[J].CA Cancer J Clin, 2016, 66 (2): 115-132.
[3] Li Z, Chen C J, Wang J K, et al.Neuroendocrine differentiation of prostate cancer[J].Asian J Androl, 2013, 15 (3): 328-332.
[4] Yuan T C, Veeramani S, Lin M F.Neuroendocrine-like prostate cancer cells:neuroendocrine transdifferentiation of prostate adenocarcinoma cells[J].Endocr Relat Cancer, 2007, 14 (3): 531-547.
[5] Hussain M, Tangen C M, Berry D L, et al.Intermittent versus continuous androgen deprivation in prostate cancer[J].N Engl J Med, 2013, 368 (14): 1314-1325.
[6] 魏建国, 王诚, 滕晓东.对WHO前列腺癌伴神经内分泌分化诊断标准的解读[J].中华病理学杂志, 2016, 45 (10): 727-730.
[7] 杜君, 陈倩倩, 杨庆.去势治疗诱导的神经内分泌前列腺癌的研究进展[J].中国肿瘤临床, 2016, 43 (2): 86-88.
[8] Huang L, Zhou J G, Yao W X, et al.Systematic review and meta-analysis of the efficacy of serum neuron-specific enolase for early small cell lung cancer screening[J].Oncotarget, 2017, 8 (38): 64358-64372.
[9] 李龙, 朱文尧, 陶泽宇, 等.P504s在前列腺癌中的表达研究[J].中国现代医生, 2017, 55 (29): 6-8.
[10] 马志伟, 董丹丹, 龚百生, 等.P504S在前列腺癌、肾细胞癌和膀胱尿路上皮癌中的表达及临床意义[J].临床与病理杂志, 2015, 35 (7): 1276-1281.
[11] Tosoian J J, Gorin M A, Ross A E, et al.Oligometastatic prostate cancer:definitions, clinical outcomes, and treatment considerations[J].Nat Rev Urol, 2017, 14 (1): 15-25.
[12] Kim J, Park J S, Ham W S.The role of metastasis-directed therapy and local therapy of the primary tumor in the management of oligometastatic prostate cancer[J].Investig Clin Urol, 2017, 58 (5): 307-316.
[13] Rusthoven C G, Jones B L, Flaig T W, et al.Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer[J].J Clin Oncol, 2016, 34 (24): 2835-2842.
[14] Satkunasivam R, Kim A E, Desai M, et al.Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer:A SEER-Medicare Analysis[J].J Urol, 2015, 194 (2): 378-385.
[15] Mathieu R, Korn S M, Bensalah K, et al.Cytoreductive radical prostatectomy in metastatic prostate cancer:Does it really make sense?[J].World J Urol, 2016, 35 (4): 1-11.
[16] 许传亮, 常易凡, 孙颖浩.寡转移前列腺癌手术治疗的相关问题[J].临床泌尿外科杂志, 2017, 32 (9): 653-657.
[17] Heidenreich A, Fossati N, Suardi N, et al.The role of cytoreductive radical prostatectomy (cRP) in men with hormone-sensitive, metastatic prostate cancer (mPCA) [J].J Clin Oncol, 2017, 35 (6_suppl): 241-241.
-
计量
- 文章访问数: 254
- PDF下载数: 566
- 施引文献: 0
下载: